---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-001717"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2025-09-25T23:59:59+00:00"
generated_at: "2026-05-17T05:39:16.372803+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Lexaria Bioscience terminates $5M equity distribution agreement with JonesTrading

## Summary
- Terminated Capital on Demand Sales Agreement with JonesTrading effective September 19, 2025.
- Agreement allowed up to $5M in common stock; only 14,995 shares sold for $38,236 gross proceeds.
- Original agreement dated Aug 21, 2024; amended Feb 5, 2025.

## SEC filing metadata
- accession: 0001640334-25-001717
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2025-09-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033425001717/0001640334-25-001717-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033425001717/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-001717
- JSON: https://secwatch.observer/filing/0001640334-25-001717.json
- Plain text: https://secwatch.observer/filing/0001640334-25-001717.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.